Figlin R - Search Results

1

A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.

Ing N, Huang F, Conley A, You S, Ma Z, Klimov S, Ohe C, Yuan X, Amin MB, Figlin R, Gertych A, Knudsen BS. Ing N, et al. Among authors: figlin r. Sci Rep. 2017 Oct 16;7(1):13190. doi: 10.1038/s41598-017-13196-4. Sci Rep. 2017. PMID: 29038551 Free PMC article.

2

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.

Visapää H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A. Visapää H, et al. Among authors: figlin r. Urology. 2003 Apr;61(4):845-50. doi: 10.1016/s0090-4295(02)02404-4. Urology. 2003. PMID: 12670587

3

Prognostic factors in renal cell carcinoma.

Shuch BM, Lam JS, Belldegrun AS, Figlin RA. Shuch BM, et al. Semin Oncol. 2006 Oct;33(5):563-75. doi: 10.1053/j.seminoncol.2006.06.006. Semin Oncol. 2006. PMID: 17045085 Review.

4

Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.

Lam JS, Breda A, Belldegrun AS, Figlin RA. Lam JS, et al. J Clin Oncol. 2006 Dec 10;24(35):5565-75. doi: 10.1200/JCO.2006.08.1794. J Clin Oncol. 2006. PMID: 17158542 Review.

5

Novel agents and approaches for advanced renal cell carcinoma.

Figlin R, Sternberg C, Wood CG. Figlin R, et al. J Urol. 2012 Sep;188(3):707-15. doi: 10.1016/j.juro.2012.04.108. Epub 2012 Jul 19. J Urol. 2012. PMID: 22818130 Review.

6

Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell Cancer.

Kumbla RA, Figlin RA, Posadas EM. Kumbla RA, et al. Drugs. 2017 Jan;77(1):17-28. doi: 10.1007/s40265-016-0665-1. Drugs. 2017. PMID: 27995579 Review.

7

Circulating tumor cells in prostate cancer: beyond enumeration.

Chen JF, Lu YT, Cheng S, Tseng HR, Figlin RA, Posadas EM. Chen JF, et al. Clin Adv Hematol Oncol. 2017 Jan;15(1):63-73. Clin Adv Hematol Oncol. 2017. PMID: 28212371

8

Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma.

Adashek JJ, Salgia MM, Posadas EM, Figlin RA, Gong J. Adashek JJ, et al. Clin Genitourin Cancer. 2019 Jun;17(3):e454-e460. doi: 10.1016/j.clgc.2019.01.004. Epub 2019 Jan 15. Clin Genitourin Cancer. 2019. PMID: 30733185 Review.

9

Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.

Tamukong PK, Kuhlmann P, You S, Su S, Wang Y, Yoon S, Gong J, Figlin RA, Janes JL, Freedland SJ, Halabi S, Small EJ, Rini BI, Kim HL. Tamukong PK, et al. Among authors: figlin ra. Urol Oncol. 2022 Nov;40(11):495.e1-495.e10. doi: 10.1016/j.urolonc.2022.07.010. Epub 2022 Aug 13. Urol Oncol. 2022. PMID: 35973929

10

Immunotherapy for renal cell carcinoma.

Belldegrun A, Figlin R, Danella J, deKernion J. Belldegrun A, et al. Among authors: figlin r. Semin Urol. 1992 Feb;10(1):23-7. Semin Urol. 1992. PMID: 1565900 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page